ArticleInternational journal of public health2026
Burden trends and disparities of metabolic risk-attributable peripheral arterial disease in China (1990-2035): a comparative analysis with G20 countries.
Article in International journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Peripheral arterial disease (PAD) presents a significant clinical and public health challenge. This study aimed to comprehensively analyze and compare the burden trends and disparities of PAD attributable to metabolic risks in China and G20 countries. Methods: Disability-adjusted life years (DALYs), age-standardized rates, population-attributable fractions, and average annual percentage changes (AAPCs) were used as the burden metrics. Decomposition analysis was conducted to quantify the contributions of population growth, aging, and epidemiological changes. The autoregressive integrated moving average (ARIMA) model was applied to project future burden trends. Results: In 2023, China and G20 countries had 100 298 and 704 214 DALYs of PAD attributable to metabolic risks, respectively. Compared to 1990, these figures increased by 210.9% and 114.6%, respectively. Population growth and aging were major drivers of the increasing PAD burden. Significant disparities were observed across ages and sexes. Moreover, projections indicate an increasing DALYs in China and G20 countries by 2035. Conclusion: Our findings reveal a substantial and growing absolute PAD burden attributable to metabolic risks in China and G20 countries, with China exhibiting a distinct epidemiological pattern.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.